Estimating the potential health impact of tamoxifen risk reduction.

被引:0
|
作者
Everson, RB [1 ]
机构
[1] Wayne State Univ, Karmanos Canc Inst, Detroit, MI 48201 USA
关键词
D O I
暂无
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
860
引用
收藏
页码:S232 / S232
页数:1
相关论文
共 50 条
  • [11] Residential exposure to pesticides: Advances in exposure assessment and risk reduction.
    Fenske, RA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 229 : U71 - U71
  • [12] Comparison of different functional food approaches to cardiovascular risk reduction.
    Gruenwald, J
    JOURNAL OF NUTRITION, 2002, 132 (03): : 610S - 610S
  • [13] Estimating risk reduction required to break even in a health promotion program
    Ozminkowski, RJ
    Goetzel, RZ
    Santoro, J
    Saenz, BJ
    Eley, C
    Gorsky, B
    AMERICAN JOURNAL OF HEALTH PROMOTION, 2004, 18 (04) : 316 - 325
  • [14] Impact of the Prevention Plan on Employee Health Risk Reduction
    Loeppke, Ronald
    Edington, Dee W.
    Beg, Sami
    POPULATION HEALTH MANAGEMENT, 2010, 13 (05) : 275 - 284
  • [15] Tamoxifen for breast cancer risk reduction: Is it acceptable to women at risk?
    Melnikow, J
    Paterniti, D
    Jim, N
    Kuenneth, C
    Birch, S
    Kuppermann, M
    Azari, R
    DeGregorio, M
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 : 303 - 304
  • [16] MODEL OF PISTON IMPACT AND VIBRATION FOR INTERNAL COMBUSTION ENGINE NOISE REDUCTION.
    Seybert, A.F.
    Hamilton, J.F.
    Hayes, P.A.
    Archives of Acoustics, 1981, 6 (02) : 89 - 109
  • [17] Dietary practices of black and white adolescents: Focus on cancer risk reduction.
    Bozemann, K
    Cook, L
    Weatherspoon, L
    Rankins, J
    FASEB JOURNAL, 1998, 12 (04): : A568 - A568
  • [18] Bisphosphonates for cardiovascular risk reduction. A systematic review and meta-analysis
    Kranenburg, G.
    Bartsra, J. W.
    Weijmans, M.
    De Jong, P. A.
    Mali, W. P.
    Verhaar, H. J.
    Visseren, F. L. J.
    Spiering, W. S.
    EUROPEAN HEART JOURNAL, 2016, 37 : 31 - 32
  • [19] Costs and benefits of opisthobranch swimming: Neurobehavioral mechanisms underlying risk reduction.
    Willows, AOD
    AMERICAN ZOOLOGIST, 1999, 39 (05): : 110A - 110A
  • [20] The raloxifene plus zoladex (RAZOR) trial for breast cancer risk reduction.
    Eccles, DM
    Dowsett, M
    Howell, A
    Evans, G
    Chapman, K
    Eeles, R
    Mackay, J
    Fallowfield, L
    Cuzick, J
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2002, 11 (10) : 1194S - 1194S